Detalles de la búsqueda
1.
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
J Oncol Pharm Pract
; : 10781552241241004, 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613329
2.
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(10): 1094-1108, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37714168
3.
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study.
Acta Oncol
; 62(4): 381-390, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37083566
4.
Perspectives and Knowledge about Fertility Preservation Strategies among Female Cancer Patients in Turkey.
Int J Clin Pract
; 2023: 6193187, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36817282
5.
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Urol Int
; 107(6): 595-601, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996793
6.
Modified docetaxel, cisplatin, and 5-fluorouracil combination regimen and capecitabine maintenance in metastatic gastric cancer: toxicity and efficacy results.
Support Care Cancer
; 30(5): 4447-4455, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106659
7.
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.
Future Oncol
; 17(35): 4861-4869, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726480
8.
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer.
J Oncol Pharm Pract
; 26(5): 1110-1116, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31653193
9.
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).
J Oncol Pharm Pract
; 26(7): 1583-1589, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32054412
10.
Prognostic role of inflammatory biomarkers in metastatic breast cancer.
J BUON
; 22(3): 614-622, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28730765
11.
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer.
Clin Cancer Res
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38709220
12.
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG).
Clin Genitourin Cancer
; 22(3): 102077, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626660
13.
Case report-right atrial mass: a very rare presentation of endometrial cancer metastasis.
Eur Heart J Case Rep
; 7(10): ytad461, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37811158
14.
Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice.
Clin Genitourin Cancer
; 21(3): 334-341, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36641357
15.
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
Clin Genitourin Cancer
; 21(1): 175-182, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970759
16.
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.
Cancer Med
; 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140782
17.
Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis.
J Thorac Oncol
; 18(12): 1756-1766, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865896
18.
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.
Medicine (Baltimore)
; 102(45): e35950, 2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37960746
19.
Do we need new trials for the abiraterone, enzalutamide and cabazitaxel in metastatic castrate-resistant prostate cancer for confirmation of treatment indications?
World J Urol
; 35(3): 479-480, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27417948
20.
Cutaneous metastasis of bladder urothelial carcinoma; A rare conditions.
Urol Case Rep
; 41: 101955, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35028295